SARS-CoV-2 exploits host DGAT and ADRP for efficient replication

[1]  C. Hunter,et al.  Is IL-6 a key cytokine target for therapy in COVID-19? , 2021, Nature Reviews Immunology.

[2]  Ronald A. Li,et al.  Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 , 2021, Nature.

[3]  K. To,et al.  Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic , 2021, Emerging microbes & infections.

[4]  J. Chan,et al.  Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters , 2020, Nature Microbiology.

[5]  F. Krammer.  SARS-CoV-2 vaccines in development , 2020, Nature.

[6]  Carolina Q. Sacramento,et al.  Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators , 2020, bioRxiv.

[7]  K. To,et al.  Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target , 2020, Science Advances.

[8]  S. Chanda,et al.  Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing , 2020, Nature.

[9]  K. To,et al.  Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19) , 2020, Viruses.

[10]  Kwok-Hung Chan,et al.  Long SARS-CoV-2 nucleocapsid sequences in blood monocytes collected soon after hospital admission , 2020, bioRxiv.

[11]  Jian-Piao Cai,et al.  Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system , 2020, Pharmacological Research.

[12]  Feng Gao,et al.  Obesity Is a Risk Factor for Greater COVID-19 Severity , 2020, Diabetes Care.

[13]  M. Tay,et al.  The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.

[14]  O. Tsang,et al.  Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study , 2020, The Lancet Microbe.

[15]  Dong Yang,et al.  Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  K. To,et al.  Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[18]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[19]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[20]  K. To,et al.  SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists , 2020, Emerging microbes & infections.

[21]  H. Nauwynck,et al.  Therapeutic effect of Xanthohumol against highly pathogenic porcine reproductive and respiratory syndrome viruses. , 2019, Veterinary microbiology.

[22]  H. Nauwynck,et al.  Xanthohumol inhibits PRRSV proliferation and alleviates oxidative stress induced by PRRSV via the Nrf2–HMOX1 axis , 2019, Veterinary research.

[23]  Pingsheng Liu,et al.  Perilipin 2 and lipid droplets provide reciprocal stabilization , 2019, Biophysics Reports.

[24]  Dong Yang,et al.  SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target , 2019, Nature Communications.

[25]  Dermot F. Reilly,et al.  DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates. , 2018, Cell metabolism.

[26]  Michal K. Handzlik,et al.  The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function , 2018, Scientific Reports.

[27]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[28]  B. Westermann,et al.  Lipid Droplets Guard Mitochondria during Autophagy. , 2017, Developmental cell.

[29]  Wan-ying Wu,et al.  UHPLC-LTQ-Orbitrap MS combined with spike-in method for plasma metabonomics analysis of acute myocardial ischemia rats and pretreatment effect of Danqi Tongmai tablet. , 2015, Molecular bioSystems.

[30]  Robert V Farese,et al.  Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure* , 2014, The Journal of Biological Chemistry.

[31]  Ralf Bartenschlager,et al.  Dengue Virus- and Hepatitis C Virus-Induced Replication and Assembly Compartments: the Enemy Inside—Caught in the Web , 2014, Journal of Virology.

[32]  Ronald A. Li,et al.  A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. , 2014, Stem cells and development.

[33]  J. F. Stevens,et al.  Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. , 2014, Molecular nutrition & food research.

[34]  K. To,et al.  Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation , 2013, The Journal of infectious diseases.

[35]  C. Hellerbrand,et al.  Xanthohumol feeding does not impair organ function and homoeostasis in mice. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  S. Ōmura,et al.  Expression of two human acyl-CoA:diacylglycerol acyltransferase isozymes in yeast and selectivity of microbial inhibitors toward the isozymes , 2009, The Journal of Antibiotics.

[37]  Robert V Farese,et al.  Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. , 2008, Journal of lipid research.

[38]  Laura Moody,et al.  Hepatitis C Virus Core Protein Induces Lipid Droplet Redistribution in a Microtubule‐ and Dynein‐Dependent Manner , 2008, Traffic.

[39]  Robert V Farese,et al.  Lipopenia and Skin Barrier Abnormalities in DGAT2-deficient Mice* , 2004, Journal of Biological Chemistry.

[40]  Robert V Farese,et al.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat , 2000, Nature Genetics.

[41]  K. Feingold,et al.  Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. , 1989, The Journal of clinical investigation.